Establishment of a System for Precision Medicine of Cardiovascular Diseases
Not Applicable
- Conditions
- Cardiovascular Diseases
- Registration Number
- JPRN-UMIN000028276
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
o genomic and transcriptomic alterations characteristic of the common phenotype were observed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Variants
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What genomic and transcriptomic biomarkers identify cardiovascular disease subtypes in JPRN-UMIN000028276?
How does precision medicine in JPRN-UMIN000028276 compare to standard-of-care for atherosclerosis and heart failure?
Which molecular pathways are targeted by Keio University's cardiovascular precision medicine system?
What adverse events are associated with genomic profiling in observational cardiovascular trials like JPRN-UMIN000028276?
How do transcriptomic alterations in JPRN-UMIN000028276 inform novel drug targets for ischemic heart disease?